SMEs can apply for a share of £1.5 million to support the evaluation of innovative medical devices, diagnostics and regulated digital health products.
Programme: Innovate UK
Award: Share of up to £1.5 million
Opens: 23rd Apr 2019
Closes: 3rd Jul 2019
The Office for Life Sciences (OLS) will work with Innovate UK, as part of UK Research and Innovation, to invest up to £1.5 million in innovation projects. These will support developers of innovative medical devices, diagnostics and regulated digital technology to evaluate their product in a real world clinical setting.
This competition is aimed at SMEs that have developed and manufactured innovative medical devices, diagnostics or regulated digital healthcare products.
You must have gained a CE marking for your product and it must already be available for the NHS to purchase, but not marketed in the UK for more than 5 years. You must collect supporting clinical evidence of its performance, cost effectiveness and impact in the NHS. If Innovate UK decide to fund you, this evidence may help increase uptake of your product within the NHS.
The competition will support the development or design of plans for the collection of clinical data in a real-world setting, and also support the running of these studies.
Your proposal must:
Your project must:
Priority will be given to projects that are related to:
To lead a project or work alone you must:
SMEs can work alone or in collaboration with other businesses or research organisations as non grant claiming partners or sub-contractors. Only the SME leading the project will be eligible to claim grant funding.
Up to £1.5 million has been allocated to fund projects in this competition. You can apply for funding of up to 50% of your total eligible project costs.
Material and capital usage costs are ineligible. If these costs are included your application will be ruled as ineligible and will not be funded.
Option 1: total project costs of up to £50,000
SMEs can apply for support to develop detailed and feasible plans for the collection of relevant data in a clinical setting. It is expected that such planning and evidence collection will involve discussion with appropriate stakeholders such as the NIHR, NICE and AHSNs.
Option 2: total project costs of up to £250,000
SMEs can apply for support to collect and analyse real world data that helps evaluate the impact of a product. Plans for the collection and analysis of real world data must have been developed in discussion with appropriate stakeholders, such as NIHR, NICE and AHSNs.
You can use the funding to:
Projects will not be eligible for funding under this competition if they involve: